Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small cell lung cancer: the Tarceva Lung Cancer Investigation Trial. - Gatzemeier,U.; Pluzanska,A.; Szczesna,A.; Kaukel,E.; Roubec,J.; De Rosa,F.; Milanowski,J.; Karnicka-Mlodkowski,H.; Pesek,M.; Serwatowski,P.; Ramlau,R.; Janaskova,T.; et al. (J Clin Oncol, 2007)